{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:41:21Z","timestamp":1790138481254,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.leukres.2024.107635","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:59:22Z","timestamp":1733421562000},"page":"107635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)"],"prefix":"10.1016","volume":"148","author":[{"given":"Devon A.","family":"Weterings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen G.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.leukres.2024.107635_bib1","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","article-title":"HTLV-1\u2013infected T cells contain a single integrated provirus in natural infection","volume":"120","author":"Cook","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107635_bib2","first-page":"43","article-title":"Human T cell leukemia virus type 1: persistence and pathogenesis","volume":"36","author":"Bangham","year":"2017","journal-title":"Annu. Rev."},{"key":"10.1016\/j.leukres.2024.107635_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.leukres.2024.107635_bib4","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/bjh.15234","article-title":"Can we reduce the incidence of adult T-cell leukaemia\/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom","volume":"184","author":"Malik","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.leukres.2024.107635_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107635_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.leukres.2024.107635_bib7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.3575.3575","article-title":"A Long-Term Study on Indolent Adult T-Cell Leukemia\/Lymphoma (ATLL)","volume":"110","author":"Takasaki","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2024.107635_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front. Microbiol."},{"issue":"125","key":"10.1016\/j.leukres.2024.107635_bib9","article-title":"Prevalence and risk factors of HTLV-1\/2 and other blood borne infectious diseases among blood donors in Yaounde Central Hospital, Cameroon","volume":"30","author":"Michel","year":"2018","journal-title":"Pan Afr. Med. J."},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3201\/eid2504.180984","article-title":"Self-Flagellation as Possible Route of Human T-Cell Lymphotropic Virus Type-1 Transmission","volume":"25","author":"Tang","year":"2019","journal-title":"Emerg. Infect. Dis. J."},{"issue":"5613","key":"10.1016\/j.leukres.2024.107635_bib11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12977-015-0236-7","article-title":"Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients","volume":"13","author":"Cook","year":"2016","journal-title":"Retrovirology"},{"issue":"9","key":"10.1016\/j.leukres.2024.107635_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007470","article-title":"The relative contributions of infectious and mitotic spread to HTLV-1 persistence","volume":"16","author":"Laydon","year":"2020","journal-title":"PLOS Comput. Biol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/0008-5472.CAN-13-0436","article-title":"HTLV-1 bZIP Factor Suppresses Apoptosis by Attenuating the Function of FoxO3a and Altering Its Localization","volume":"74","author":"Tanaka-Nakanishi","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.leukres.2024.107635_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.leukres.2024.107635_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003646","article-title":"Quantification of HTLV-1 Clonality and TCR Diversity","volume":"10","author":"Laydon","year":"2014","journal-title":"PLoS Comput. Biol."},{"issue":"11","key":"10.1016\/j.leukres.2024.107635_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006030","article-title":"T Cell Receptor V\u03b2 Staining Identifies the Malignant Clone in Adult T cell Leukemia and Reveals Killing of Leukemia Cells by Autologous CD8+\u2009T cells","volume":"12","author":"Rowan","year":"2016","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.leukres.2024.107635_bib18","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","article-title":"The Role of CTLs in Persistent Viral Infection: Cytolytic Gene Expression in CD8+\u2009Lymphocytes Distinguishes between Individuals with a High or Low Proviral Load of Human T Cell Lymphotropic Virus Type 1","volume":"173","author":"Vine","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107635_bib19","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","article-title":"CTL quality and the control of human retroviral infections","volume":"39","author":"Bangham","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.leukres.2024.107635_bib20","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"29","key":"10.1016\/j.leukres.2024.107635_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aao2892","article-title":"Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+\u2009T cell\u2013mediated control of HIV-1, HCV, and HTLV-1","volume":"3","author":"Boelen","year":"2018","journal-title":"Sci. Immunol."},{"issue":"6","key":"10.1016\/j.leukres.2024.107635_bib22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease","volume":"177","author":"Elovaara","year":"1993","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.leukres.2024.107635_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0042-6822(92)90517-S","article-title":"Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis","volume":"188","author":"Parker","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.leukres.2024.107635_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.12688\/wellcomeopenres.12469.2","article-title":"Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1","volume":"2","author":"Billman","year":"2017","journal-title":"Wellcome Open Res."},{"issue":"6","key":"10.1016\/j.leukres.2024.107635_bib25","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1715724115","article-title":"Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells","volume":"115","author":"Mahgoub","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/jiq078","article-title":"In vivo Expression of Human T-lymphotropic Virus Type 1 Basic Leucine-Zipper Protein Generates Specific CD8+\u2009and CD4+\u2009T-Lymphocyte Responses that Correlate with Clinical Outcome","volume":"203","author":"Hilburn","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"9","key":"10.1016\/j.leukres.2024.107635_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"MacNamara","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12977-014-0116-6","article-title":"Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression","volume":"11","author":"Rowan","year":"2014","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.leukres.2024.107635_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001274","article-title":"HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo","volume":"7","author":"Satou","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.leukres.2024.107635_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+\u2009T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"issue":"17","key":"10.1016\/j.leukres.2024.107635_bib31","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLOS Pathog."},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation oftax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2024.107635_bib34","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.leukres.2024.107635_bib35","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.leukres.2024.107635_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150472","article-title":"HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/lymphoma","volume":"131","author":"Tan","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/2643-3230.BCD-21-0044","article-title":"Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1","volume":"2","author":"Koya","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"7607","key":"10.1016\/j.leukres.2024.107635_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.leukres.2024.107635_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135042","article-title":"The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia","volume":"10","author":"Maeda","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V76.5.971.971","article-title":"Kaposi\u2019s Sarcoma in Human T-Cell Leukemia Virus Type I-Associated Adult T-Cell Leukemia","volume":"76","author":"Greenberg","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2024.107635_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12185-018-2552-x","article-title":"Epstein\u2013Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution","volume":"109","author":"Kamachi","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"43","key":"10.1016\/j.leukres.2024.107635_bib42","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1038\/sj.onc.1203870","article-title":"High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis","volume":"19","author":"Gabet","year":"2000","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib43","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.leu.2403176","article-title":"Loss of the ex vivo but not the reinducible CD8+\u2009T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia\/lymphoma","volume":"18","author":"Arnulf","year":"2004","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.leukres.2024.107635_bib44","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.177.8.5718","article-title":"Reduced Frequency, Diversity, and Function of Human T Cell Leukemia Virus Type 1-Specific CD8+\u2009T Cell in Adult T Cell Leukemia Patients","volume":"177","author":"Kozako","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1742-4690-8-100","article-title":"Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+\u2009T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers","volume":"8","author":"Takamori","year":"2011","journal-title":"Retrovirology"},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.leukres.2024.107635_bib47","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2024.107635_bib48","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/bmt.2014.143","article-title":"Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP","volume":"49","author":"Bazarbachi","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib49","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/icb.2016.127","article-title":"Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine","volume":"95","author":"Smith","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.leukres.2024.107635_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231204198","article-title":"Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies","volume":"22","author":"Zhao","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010047","article-title":"Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation","volume":"8","author":"Ottaviano","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib52","doi-asserted-by":"crossref","DOI":"10.34067\/KID.0001572021","article-title":"Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients","volume":"2","author":"Parajuli","year":"2021","journal-title":"Kidney360"},{"issue":"6","key":"10.1016\/j.leukres.2024.107635_bib53","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.ymthe.2022.02.002","article-title":"The generation and application of antigen-specific T cell therapies for cancer and viral-associated disease","volume":"30","author":"Hont","year":"2022","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.leukres.2024.107635_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-200205270-00014","article-title":"Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1","volume":"73","author":"Smets","year":"2002","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib55","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of epstein-barr virus\u2013induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.leukres.2024.107635_bib56","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.leukres.2024.107635_bib57","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+\u2009lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"issue":"9331","key":"10.1016\/j.leukres.2024.107635_bib58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":"Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib59","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2006-12-063008","article-title":"Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial","volume":"110","author":"Haque","year":"2007","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.leukres.2024.107635_bib60","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/0008-5472.CAN-03-1452","article-title":"Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation","volume":"64","author":"Harashima","year":"2004","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.leukres.2024.107635_bib62","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/cam4.4689","article-title":"HTLV-1 Tax-specific memory cytotoxic T lymphocytes in long-term survivors of aggressive-type adult T-cell leukemia\/lymphoma","volume":"11","author":"Jo","year":"2022","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.leukres.2024.107635_bib63","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.21873\/anticanres.14527","article-title":"Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia\/lymphoma","volume":"40","author":"Jo","year":"2020","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib64","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00262-022-03301-6","article-title":"Live attenuated VZV vaccination induces antitumor immunity in ATLL patients","volume":"72","author":"Jo","year":"2023","journal-title":"Cancer Immunol., Immunother."},{"issue":"3","key":"10.1016\/j.leukres.2024.107635_bib65","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.13302","article-title":"Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia\/lymphoma in a pilot study","volume":"169","author":"Suehiro","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.leukres.2024.107635_bib66","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1182\/blood-2015-04-641118","article-title":"Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor","volume":"126","author":"Sugata","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.leukres.2024.107635_bib67","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.3390\/ijms24076300","article-title":"CAR T Cell Therapy: A Versatile Living Drug","volume":"24","author":"De Marco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.leukres.2024.107635_bib68","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/mmr.2024.13171","article-title":"CAR-T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)","volume":"29","author":"Sun","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1365-2567.2000.00001.x","article-title":"CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes","volume":"100","author":"Exley","year":"2000","journal-title":"Immunology"},{"issue":"21","key":"10.1016\/j.leukres.2024.107635_bib70","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1182\/blood-2011-11-389304","article-title":"Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Chaidos","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.leukres.2024.107635_bib71","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1182\/blood-2014-11-612762","article-title":"Third-party CD4+\u2009invariant natural killer T cells protect from murine GVHD lethality","volume":"125","author":"Schneidawind","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2024.107635_bib72","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/leu.2016.281","article-title":"Pre-transplant donor CD4\u2212 invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease","volume":"31","author":"Rubio","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2024.107635_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1118681","article-title":"CAR-iNKT cells targeting clonal TCRV\u03b2 chains as a precise strategy to treat T cell lymphoma","volume":"14","author":"Rowan","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.leukres.2024.107635_bib74","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/nm.4444","article-title":"Targeting the T cell receptor \u03b2-chain constant region for immunotherapy of T cell malignancies","volume":"23","author":"Maciocia","year":"2017","journal-title":"Nat. Med."},{"issue":"ement 1","key":"10.1016\/j.leukres.2024.107635_bib75","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1182\/blood-2022-165971","article-title":"First in Human Study of AUTO4, a TRBC1-Targeting CAR T-Cell Therapy in Relapsed\/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma","volume":"140","author":"Cwynarski","year":"2022","journal-title":"Blood"},{"issue":"8007","key":"10.1016\/j.leukres.2024.107635_bib76","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-024-07233-2","article-title":"TRBC1-targeting antibody\u2013drug conjugates for the treatment of T cell cancers","volume":"628","author":"Nichakawade","year":"2024","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.leukres.2024.107635_bib77","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2024.107635_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-021-00458-8","article-title":"Quantification of T cell clonality in human T cell leukaemia virus type-1 carriers can detect the development of adult T cell leukaemia early","volume":"11","author":"Wolf","year":"2021","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.leukres.2024.107635_bib79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/cam4.928","article-title":"Risk stratification of adult T-cell leukemia\/lymphoma using immunophenotyping","volume":"6","author":"Kagdi","year":"2017","journal-title":"Cancer Med."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212624002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T15:01:19Z","timestamp":1736780479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212624002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":79,"alternative-id":["S0145212624002017"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107635","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2024.107635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107635"}}